1WM
REGN icon

1900 Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

1900 Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$478K Buy
+630
New +$476K 0.03% 215

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return

1900 Wealth Management's REGN Position: Q3 2026 in Review

1900 Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 630 shares worth $478K. The stake represents 0.03% of the portfolio and ranks #215 among its holdings.

122 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • 1900 Wealth Management held 630 shares of Regeneron Pharmaceuticals worth $478K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new 1900 Wealth Management position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.03% of 1900 Wealth Management's portfolio in Q3 2026, its #215 holding.
  • 122 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on 1900 Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.